Angiography News and Research

RSS

AstraZeneca receives FDA approval for BRILINTA to treat acute coronary syndrome

AstraZeneca announced today that the US Food and Drug Administration (FDA) has approved BRILINTA (ticagrelor) tablets to reduce the rate of heart attack and cardiovascular (CV) death in adult patients with acute coronary syndrome (ACS), compared to clopidogrel.

21 Jul 2011

New report: Global cardiac catheters market to reach US$2.1B by 2015

The global cardiac catheters market is forecast to reach US$2.1 billion by 2015 at a CAGR of 12.9% during the analysis period 2009-2015, according to a new report available on companiesandmarkets.com.

20 Jul 2011

Coronary CTA non-invasive and safe for children

Coronary computed tomography angiography (CTA) has excellent image quality and diagnostic confidence for the entire spectrum of pediatric patients, with significant reduction of risk with recent technological advancements, according to a study to be presented at the Sixth Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography (SCCT) in Denver, July 14-17.

18 Jul 2011

Rcadia reports promising results from calcium scoring cCTA trial

Rcadia Medical Imaging has achieved proof-of-concept with the first fully automated software that performs calcium scoring directly from a coronary CT angiography (cCTA) study.

15 Jul 2011

Coronary artery disease is a predictor for new-onset atrial fibrillation after heart attack

Results from a case control study show that coronary artery disease affecting the atrial branches is an independent predictor for new-onset atrial fibrillation (AF) after acute myocardial infarction (MI), or heart attack.

12 Jul 2011

ThromboView gets positive results in study evaluating accuracy and safety

Drug and diagnostic company Agenix Limited (ASX: AGX), today announced the positive results of a study to evaluate the efficacy and accuracy

7 Jul 2011

New data compares gender effect on survival after abdominal aortic aneurysm repair

New data in the July 2011 issue of the Journal of Vascular Surgery, the official publication of the Society for Vascular Surgery, compares the effects of gender on long-term survival in different types of abdominal aortic aneurysm (AAA) repair.

7 Jul 2011

Lantheus commences flurpiridaz F 18 PET MPI Phase 3 trial for detection of coronary artery disease

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the initiation of the first of two Phase 3 clinical trials to assess myocardial perfusion using Positron Emission Tomography (PET) imaging with flurpiridaz F 18 in patients with suspected or known coronary artery disease (CAD).

1 Jul 2011

Coronary CT angiography may effectively screen for heart disease in African-Americans

Researchers may have discovered one reason that African Americans are at increased risk for heart attacks and other cardiovascular events.

28 Jun 2011

ULMCA PCI with DES a viable option for low-risk patients with normal left ventricular function

23 Jun 2011

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Patients with normal left ventricular function who undergo elective unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) with drug-eluting stents (DES) had favorable outcomes according to new research. Results of the multicenter, retrospective study are reported in the June issue of Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions (SCAI).

22 Jun 2011

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

22 Jun 2011

ESC publishes position paper to raise the profile of vulnerable plaques

The European Society of Cardiology (ESC) Working Group of Atherosclerosis and Vascular Biology has published a position paper to raise the profile of vulnerable plaques and the need for greater use of therapies to promote plaque stabilisation.

15 Jun 2011

CorMedix completes enrollment in CRMD001 Phase II trial for treatment of acute kidney injury

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, announced it successfully completed patient enrollment in its phase II Contrast-Induced Acute Kidney Injury study with its oral drug candidate CRMD001.

14 Jun 2011

Study determines surfactant protein-D as 'a good predictor' of cardiovascular disease

A blood protein known as surfactant protein-D (SP-D), which is mainly synthesised in the lungs, has been described as "a good predictor" of cardiovascular disease following a large study in North America.

8 Jun 2011

Asymptomatic patients do not benefit from CT angiography screening

Coronary computed tomographic angiography, which can detect plaque buildup in heart vessels, is sometimes used as a screening tool to assess the risk for a heart attack. However, the usefulness of the test on low-risk patients who do not have coronary symptoms, such as chest pain, has been unclear.

24 May 2011

Transarterial embolization an effective alternative to endoscopy for acute peptic ulcer bleeding

Researchers from China report that in patients with peptic ulcer bleeding in whom endoscopy failed to control the bleeding, transarterial embolization is a safe procedure which reduces the need for surgery without increasing overall mortality and is associated with few complications.

24 May 2011

Morris Hospital installs Toshiba's Ultimax X-ray system to streamline diagnosis, improve patient throughput

Advancements in diagnostic imaging technology are enabling healthcare facilities to achieve multifunctional capabilities using a single modality. To streamline diagnosis and improve patient throughput, Morris Hospital has installed the Ultimax X-ray system from Toshiba America Medical Systems, Inc.

23 May 2011

Positive six-month results from BIOSOLVE-I FIM trial of DRug-Eluting Absorbable Metal Scaffold device

Six-month results from the BIOSOLVE-I first-in-man (FIM) trial, studying the DRug-Eluting Absorbable Metal Scaffold (DREAMS), demonstrate a high safety profile of the novel device.

19 May 2011

Abiomed fiscal fourth quarter revenue increases 24% to $28.5 million

Abiomed, Inc., a leading provider of breakthrough heart support technologies, today reported fourth quarter fiscal 2011 revenue of $28.5 million, up 24% compared to revenue of $23.0 million in the same period of fiscal 2010.

18 May 2011

Angiography News and Research

AstraZeneca receives FDA approval for BRILINTA to treat acute coronary syndrome

New report: Global cardiac catheters market to reach US$2.1B by 2015

Coronary CTA non-invasive and safe for children

Rcadia reports promising results from calcium scoring cCTA trial

Coronary artery disease is a predictor for new-onset atrial fibrillation after heart attack

ThromboView gets positive results in study evaluating accuracy and safety

New data compares gender effect on survival after abdominal aortic aneurysm repair

Lantheus commences flurpiridaz F 18 PET MPI Phase 3 trial for detection of coronary artery disease

Coronary CT angiography may effectively screen for heart disease in African-Americans

ULMCA PCI with DES a viable option for low-risk patients with normal left ventricular function

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

ESC publishes position paper to raise the profile of vulnerable plaques

CorMedix completes enrollment in CRMD001 Phase II trial for treatment of acute kidney injury

Study determines surfactant protein-D as 'a good predictor' of cardiovascular disease

Asymptomatic patients do not benefit from CT angiography screening

Transarterial embolization an effective alternative to endoscopy for acute peptic ulcer bleeding

Morris Hospital installs Toshiba's Ultimax X-ray system to streamline diagnosis, improve patient throughput

Positive six-month results from BIOSOLVE-I FIM trial of DRug-Eluting Absorbable Metal Scaffold device

Abiomed fiscal fourth quarter revenue increases 24% to $28.5 million

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News